Rovati LC - Search Results

1

Avoidance of vertebral fractures in men with idiopathic osteoporosis by a three year therapy with calcium and low-dose intermittent monofluorophosphate.

Ringe JD, Dorst A, Kipshoven C, Rovati LC, Setnikar I. Ringe JD, et al. Among authors: rovati lc. Osteoporos Int. 1998;8(1):47-52. doi: 10.1007/s001980050047. Osteoporos Int. 1998. PMID: 9692077 Clinical Trial.

2

Correct regimen of fluoride and calcium reduces the risk of vertebral fractures in postmenopausal osteoporosis.

Reginster JY, Rovati LC, Setnikar I. Reginster JY, et al. Among authors: rovati lc. Osteoporos Int. 2001;12(9):800. doi: 10.1007/s001980170058. Osteoporos Int. 2001. PMID: 11605748 No abstract available.

3

Treatment of osteoporosis in men with fluoride alone or in combination with bisphosphonates.

Ringe JD, Rovati LC. Ringe JD, et al. Among authors: rovati lc. Calcif Tissue Int. 2001 Oct;69(4):252-5. doi: 10.1007/s00223-001-1050-x. Calcif Tissue Int. 2001. PMID: 11730262 Review.

4

Efficacy of etidronate and sequential monofluorophosphate in severe postmenopausal osteoporosis: a pilot study.

Ringe JD, Dorst A, Faber H, Kipshoven C, Rovati LC, Setnikar I. Ringe JD, et al. Among authors: rovati lc. Rheumatol Int. 2005 May;25(4):296-300. doi: 10.1007/s00296-004-0570-x. Epub 2005 Mar 16. Rheumatol Int. 2005. PMID: 15770482 Clinical Trial.

5

The effect of sodium monofluorophosphate plus calcium on vertebral fracture rate in postmenopausal women with moderate osteoporosis. A randomized, controlled trial.

Reginster JY, Meurmans L, Zegels B, Rovati LC, Minne HW, Giacovelli G, Taquet AN, Setnikar I, Collette J, Gosset C. Reginster JY, et al. Among authors: rovati lc. Ann Intern Med. 1998 Jul 1;129(1):1-8. doi: 10.7326/0003-4819-129-1-199807010-00001. Ann Intern Med. 1998. PMID: 9652994 Clinical Trial.

6

Bioavailability and pharmacokinetic characteristics of two monofluorophosphate preparations with calcium supplement.

Setnikar I, Rovati LC, Schmid K, Vens-Cappell B, Barkworth MF. Setnikar I, et al. Among authors: rovati lc. Arzneimittelforschung. 1998 Dec;48(12):1172-8. Arzneimittelforschung. 1998. PMID: 9893933 Clinical Trial.

7

Dose-response efficacy of a new estradiol transdermal matrix patch for 7-day application: a randomized, double-blind, placebo-controlled study. Italian Menopause Research Group.

Rovati LC, Setnikar I, Genazzani AR. Rovati LC, et al. Gynecol Endocrinol. 2000 Aug;14(4):282-91. doi: 10.3109/09513590009167695. Gynecol Endocrinol. 2000. PMID: 11075300 Clinical Trial.

8

Efficacy and safety of intramuscular glucosamine sulfate in osteoarthritis of the knee. A randomised, placebo-controlled, double-blind study.

Reichelt A, Förster KK, Fischer M, Rovati LC, Setnikar I. Reichelt A, et al. Among authors: rovati lc. Arzneimittelforschung. 1994 Jan;44(1):75-80. Arzneimittelforschung. 1994. PMID: 8135881 Clinical Trial.

9

Glucosamine sulfate in osteoarthritis of the knee.

Noack W, Fischer M, Förster KK, Rovati LC, Setnikar I. Noack W, et al. Among authors: rovati lc. Osteoarthritis Cartilage. 1994 Mar;2(1):51-9. doi: 10.1016/s1063-4584(05)80006-8. Osteoarthritis Cartilage. 1994. PMID: 11548224 Clinical Trial.

10

Glucosamine sulfate compared to ibuprofen in osteoarthritis of the knee.

Müller-Fassbender H, Bach GL, Haase W, Rovati LC, Setnikar I. Müller-Fassbender H, et al. Among authors: rovati lc. Osteoarthritis Cartilage. 1994 Mar;2(1):61-9. doi: 10.1016/s1063-4584(05)80007-x. Osteoarthritis Cartilage. 1994. PMID: 11548225 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

193 results

Search Page